You are on page 1of 7

Eagle Eye Equities

November 09, 2023

Index
Punter’s Call
Looking Trendy: Nifty
Looking Trendy: Sensex
Nifty Trader
Smart Charts
Momentum Swing
Positional Weekly (Cash Only)
Positional 15 Days (Cash Only)
CTFT (Carry Today For Tomorrow) - Cash Only
Looking Trendy: Bank Nifty
Sensex
Bank Nifty Trader
FIN Nifty Trader
Key Indices
Day Trader’s Hit List

Visit us at www.sharekhan.com

For Private Circulation only


Sharekhan Eagle Eye Equities

Punter’s Call
Battle continues

November 08, 2023 Nifty daily: 19443.50

The Nifty opened on a flat note and consolidated for


the day and closed with gains of ~37 points. On the
daily charts, we can observe that the Nifty has been
consolidating around the resistance zone of 19450-19500
where both the Bulls and Bears are trying to defend their
respective boundaries. The hourly momentum indicator
has a negative crossover which is a sell signal and can
lead to more consolidation. On the way down, the Nifty
is trading above the key hourly moving averages 19340-
19320 which shall act as an immediate support zone
in case of a dip. On the upside a decisive close above
60-minute
19450-19500 shall lead to an extension of the current
rally till 19690. During this consolidation phase, broad
market outperformance can continue.
Other technical observations
On the daily chart, the Nifty is trading above the 20-
day moving average (DMA) and the 40-DEMA of 19394
and 19442, respectively. The momentum indicator has a
positive crossover on the daily chart.
On the hourly chart, the Nifty is trading above the 20-
hour moving average (HMA) and the 40-HEMA of 19394
and 19317, respectively. The momentum indicator has
a negative crossover on the hourly charts. The market
breadth was positive with 1338 advances and 1020 Market breadth
BSE NSE
declines on the National Stock Exchange.
Todays Close 64975.61 19443.50
Advances 2019 13338
Decline 1683 1020
Unchanged 126 96
Volume (Rs. in Cr) 4908.74 66737

November 09, 2023 2


Sharekhan Eagle Eye Equities

Looking Trendy: Nifty


Short Term Trend Medium Term Trend
Lower Upper Support / Support /
Index Trend Index Target Trend Reversal
Boundary Boundary Resistance Resistance

Nifty 18584 ßà 19500 18584 / 19500 Nifty 18084 â 19850 18084 / 19850
NOTE: Reversal on closing basis NOTE: Reversal on closing basis

Looking Trendy: Sensex


Short Term Trend Medium Term Trend
Lower Upper Support / Support /
Index Trend Index Target Trend Reversal
Boundary Boundary Resistance Resistance

Sensex 63500 ßà 65700 62460 / 65400 Sensex 61000 â 66400 61000 / 66400
NOTE: Reversal on closing basis NOTE: Reversal on closing basis

Icon guide
á
á Up Down ßà Sideways Downswing matures Upswing matures

Nifty Trader
Support Resistance
19376 19512
19308 19580
19240 19648
20 DSMA 40 DEMA
19394 19442

Smart Charts
Stop Loss Potential %
Buy Price/ Call Closing
Date Scrip Name Action (On closing P/L at Exit/ Target 1 Target 2
Sell Price Price/ CMP
Basis) Current
08 Nov 23 CUMMINSIND NOV FUT Buy 1710.00 1780.35 1780.00 -0.02% 1868.00 1926.00
08 Nov 23 DR REDDY NOV FUT Buy 5270.00 5517.85 5478.45 -0.71% 5750.00 5900.00
07 Nov 23 KOTAKBANK NOV FUT Buy 1688.00 1756.55 1753.00 -0.20% 1830.00 1875.00
06 Nov 23 RELIANCE NOV FUT Buy 2289.00 2340.95 2340.00 -0.04% 2395.00 2440.00
02 Nov 23 TVSMOTORS NOV FUT Sell Stopped Out 1561.15 1642.00 -5.18% 1481.00 1401.00
TPB: Trailing profit booked

Momentum Swing
Call Potential %
Action Stop Loss/ Buy Price/
Scrip Name Action Closing P/L at Exit/ Target 1 Target 2
Date Reversal Sell Price
Price/CMP Current
08 Nov 23 JUBLFOOD NOV FUT Buy 496.00 506.30 507.00 0.14% 522.00 538.00
1) The stop loss should be placed after 9.17am in order to avoid freak trade.
2) The same will be revised in the TradeTiger terminal every day for the pop-ups.

November 09, 2023 3


Sharekhan Eagle Eye Equities

Positional Weekly (Cash Only)


Call Potential %
Action Stop Loss/ Buy Price/
Scrip Name Action Closing P/L at Exit/ Target 1 Target 2
Date Reversal Sell Price
Price/CMP Current
08 Nov 23 GICRE Buy 222.80 230.65 229.40 -0.54% 238.90 246.90
07 Nov 23 ECLERX Buy 1999.00 2060.00 2088.85 1.40% 2124.00 2189.00
07 Nov 23 UTIAMC Buy 753.90 777.70 781.35 0.47% 804.90 829.90
03 Nov 23 ICICI BANK Buy 900.00 931.50 935.75 0.46% 960.00 980.00
NOTE: Kindly note that all stop losses in Chart Buster are on an intra-day basis.

Positional 15 Days (Cash Only)


Call Potential %
Action Stop Loss/ Buy Price/
Scrip Name Action Closing P/L at Exit/ Target 1 Target 2
Date Reversal Sell Price
Price/CMP Current
08 Nov 23 NCC Buy 144.90 153.40 156.25 1.86% 162.90 171.90
08 Nov 23 HUDCO Buy 76.90 81.45 81.05 -0.49% 85.90 89.90
08 Nov 23 IRFC Buy 71.00 74.65 75.60 1.27% 79.00 83.00
06 Nov 23 EIHOTEL Buy Booked Profit 233.20 239.20 2.57% 248.00 260.00
02 Nov 23 OLECTRA Buy 1124.00 1189.45 1173.50 -1.34% 1259.00 1329.00
02 Nov 23 SUPREMIND Buy 4249.00 4506.35 4386.55 -2.66% 4769.00 4969.00
31 Oct 23 GODREJIND Buy Booked Profit 642.35 667.10 3.85% 679.90 714.90
25 Oct 23 IPCALAB Buy Booked Profit 993.30 1033.65 4.06% 1035.00 1065.00
NOTE: Kindly note that all stop losses in Chart Buster are on an intra-day basis.
1) The stop loss should be placed after 9.17am in order to avoid freak trade.
2) The same will be revised in the TradeTiger terminal every day for the pop-ups.

CTFT (Carry Today For Tomorrow) - Cash Only


Potential%
Stop Loss/ Buy Price/ Call Closing
Date Scrip Name Action P/L at Exit/ Target 1 Target 2
Reversal Sell Price Price/CMP
Current

08 Nov 23 MAHLIFE Buy 504.90 510.00 510.20 0.04% 516.90 522.90


08 Nov 23 GMRINFRA Buy 55.80 56.45 56.65 0.35% 57.50 59.00
08 Nov 23 GAEL Buy Booked Profit 339.70 344.90 1.53% 344.90 349.90
07 Nov 23 IDBI Buy Booked Profit 62.55 63.05 0.80% 64.00 66.00
07 Nov 23 BORORENEW Buy Booked Profit 437.50 441.50 0.91% 449.00 459.00
TPB: Trailing profit booked
1) The stop loss should be placed after 9.17am in order to avoid freak trade.
2) The same will be revised in the TradeTiger terminal every day for the pop-ups.

Looking Trendy: Bank Nifty


Short Term Trend Medium Term Trend
Lower Upper Support / Support /
Index Trend Index Target Trend Reversal
Boundary Boundary Resistance Resistance

Bank Nifty 41000 ßà 44000 41000 / 44000 Bank Nifty 34750 â 44600 34750 / 44600
NOTE: Reversal on closing basis NOTE: Reversal on closing basis

Icon guide
á
á Up Down ßà Sideways Downswing matures Upswing matures

November 09, 2023 4


Sharekhan Eagle Eye Equities

Sensex
SENSEX

Support Resistance

64741 65211

64506 65446

64271 65681

20 DSMA 40 DEMA

64956 65184

Bank Nifty Trader


Bank Nifty

Support Resistance

43453 43867

43246 44074

43039 44281

20 DSMA 40 DEMA

43519 43880

FIN Nifty Trader


FIN Nifty

Support Resistance

19415 19605

19320 19700

19225 19795

20 DSMA 40 DEMA

19494 19604

November 09, 2023 5


Sharekhan Eagle Eye Equities

Key Indices
Index Lower Boundary Trend Upper Boundary Support / Resistance

Nifty Auto 15700 ßà 16700 15000 / 16700

Nifty Fin Services 19000 ßà 20000 19000 / 20000

Nifty FMCG 51000 ßà 53000 51000 / 53000

Nifty Infra 6000 ßà 6400 6000 / 6400

Nifty IT 30000 ßà 31500 30000 / 31500

Nifty Metal 6300 ßà 7000 6300 / 7000

Nifty Pharma 14600 ßà 15800 14600 / 15800

Nifty Mid Cap 100 39000 ßà 41000 39000 / 41000

Nifty Small Cap 100 12800 ßà 13500 12800 / 13500

Day Trader’s Hit List


For November 09, 2023
Support Levels Close Resistance Levels
Scrip Name Action
S2 S1 (Rs.) R1 R2
Nifty 19370.0 19415.0 19443.50 19500.0 19600.0 Buy at cmp target R1 and R2 SL S2

Bank Nifty 43450.0 43550.0 43658.65 43700.0 44000.0 Buy at cmp target R1 and R2 SL S2

Axis Bank 1010.0 1018.0 1021.70 1030.0 1045.0 Buy at cmp target R1 and R2 SL S2

Bajaj Finance 7300.0 7400.0 7459.95 7485.0 7535.0 Sell at cmp target S1 and S2 SL R2

HDFC Bank 1460.0 1485.0 1491.55 1494.0 1523.0 Buy Above R1 for a target of R2 or Sell Below S1 for a target of S2

Hindustan 2495.0 2514.0 2519.35 2545.0 2575.0 Buy at cmp target R1 and R2 SL S2
Unilever

INFOSYS 1360.0 1380.0 1391.00 1393.0 1405.0 Sell at cmp target S1 and S2 SL R2

ICICI Bank 915.0 934.0 935.75 938.0 955.0 Buy Above R1 for a target of R2 or Sell Below S1 for a target of S2

ITC 432.0 436.0 436.95 441.0 446.0 Buy at cmp target R1 and R2 SL S2

Kotak Bank 1728.0 1740.0 1746.25 1765.0 1785.0 Buy at cmp target R1 and R2 SL S2

LT 2965.0 2988.0 2996.45 3020.0 3060.0 Buy at cmp target R1 and R2 SL S2

Maruti 10120.0 10300.0 10322.30 10350.0 10530.0 Buy Above R1 for a target of R2 or Sell Below S1 for a target of S2

Reliance 2290.0 2330.0 2335.90 2340.0 2385.0 Buy Above R1 for a target of R2 or Sell Below S1 for a target of S2
Industries

SBI 574.0 579.0 580.30 585.0 593.0 Buy at cmp target R1 and R2 SL S2

SunPharma 1165.0 1173.0 1176.70 1188.0 1202.0 Buy at cmp target R1 and R2 SL S2

Tata Steel 116.0 118.0 119.05 119.5 120.5 Sell at cmp target S1 and S2 SL R2

TCS 3305.0 3345.0 3381.55 3390.0 3415.0 Sell at cmp target S1 and S2 SL R2

Titan 3280.0 3303.0 3311.85 3345.0 3385.0 Buy at cmp target R1 and R2 SL S2

Zeel 253.0 256.0 259.70 261.0 263.0 Sell at cmp target S1 and S2 SL R2

November 09, 2023 6


DISCLAIMER
This information/document has been prepared by Sharekhan Ltd. (SHAREKHAN) and is intended for use only by the person or entity to which it is
addressed to. This Document may contain confidential and/or privileged material and is not for any type of circulation and any review, retransmission,
or any other use is strictly prohibited. This information/ document is subject to changes without prior notice.
Recommendation in reports based on technical and derivatives analysis is based on studying charts of a stock’s price movement, trading volume,
outstanding positions, as opposed to focusing on a company’s fundamentals and as such, may not match with a report on a company’s fundamentals.
However, this would only apply for information/document focused on technical and derivatives research and shall not apply to reports/documents/
information focused on fundamental research.
This information/document does not constitute an offer to sell or solicitation for the purchase or sale of any financial instrument or as an official
confirmation of any transaction. Though disseminated to all customers who are due to receive the same, not all customers may receive this report
at the same time. SHAREKHAN will not treat recipients as customers by virtue of their receiving this information/report.
The information contained herein is obtained from publicly available data or other sources believed to be reliable and SHAREKHAN has not
independently verified the accuracy and completeness of the said data and hence it should not be relied upon as such. While we would endeavour
to update the information herein on reasonable basis, SHAREKHAN, its subsidiaries and associated companies, their directors and employees
(“SHAREKHAN and affiliates”) are under no obligation to update or keep the information current. Also, there may be regulatory, compliance, or other
reasons that may prevent SHAREKHAN and affiliates from doing so. This document is prepared for assistance only and is not intended to be and must
not alone be taken as the basis for an investment decision. Recipients of this report should also be aware that past performance is not necessarily
a guide to future performance and value of investments can go down as well. The user assumes the entire risk of any use made of this information.
Each recipient of this document should make such investigations as it deems necessary to arrive at an independent evaluation of an investment in
the securities of companies referred to in this document (including the merits and risks involved) and should consult its own advisors to determine
the merits and risks of such an investment. The investment discussed or views expressed may not be suitable for all investors. We do not undertake
to advise you as to any change of our views. Affiliates of Sharekhan may have issued other recommendations/ reports that are inconsistent with and
reach different conclusions from the information presented in this recommendations/report.
This information/recommendation/report is not directed or intended for distribution to, or use by, any person or entity who is a citizen or resident
of or located in any locality, state, country or other jurisdiction, where such distribution, publication, availability or use would be contrary to law,
regulation or which would subject SHAREKHAN and affiliates to any registration or licensing requirement within such jurisdiction. The securities
described herein may or may not be eligible for sale in all jurisdictions or to certain category of investors. Persons in whose possession this document
may come are required to inform themselves of and to observe such restriction.
The analyst certifies that the analyst might have dealt or traded directly or indirectly in securities of the company and that all the views expressed in
this document accurately reflect his or her personal views about the subject company or companies and its or their securities and do not necessarily
reflect those of SHAREKHAN. The analyst and SHAREKHAN further certifies that either he or his relatives or Sharekhan associates might have
direct or indirect financial interest or might have actual or beneficial ownership of 1% or more in the securities of the company at the end of the
month immediately preceding the date of publication of the research report. The analyst and SHAREKHAN encourages independence in research
report/ material preparation and strives to minimize conflict in preparation of research report. The analyst and SHAREKHAN does not have any
material conflict of interest or has not served as officer, director or employee or engaged in market making activity of the company. The analyst and
SHAREKHAN has not been a part of the team which has managed or co-managed the public offerings of the company, and no part of the analyst’s
compensation was, is or will be, directly or indirectly related to specific recommendations or views expressed in this document. Sharekhan Ltd or its
associates or analysts have not received any compensation for investment banking, merchant banking, brokerage services or any compensation or
other benefits from the subject company or from third party in the past twelve months in connection with the research report.
Either SHAREKHAN or its affiliates or its directors or employees / representatives / clients or their relatives may have position(s), make market, act
as principal or engage in transactions of purchase or sell of securities, from time to time or may be materially interested in any of the securities or
related securities referred to in this report and they may have used the information set forth herein before publication. SHAREKHAN may from time
to time solicit from, or perform investment banking, or other services for, any company mentioned herein. Without limiting any of the foregoing, in
no event shall SHAREKHAN, any of its affiliates or any third party involved in, or related to, computing or compiling the information have any liability
for any damages of any kind.
Forward-looking statements (if any) are provided to allow potential investors the opportunity to understand management’s beliefs and opinions in
respect of the future so that they may use such beliefs and opinions as one factor in evaluating an investment. These statements are not a guarantee
of future performance and undue reliance should not be placed on them. Such forward-looking statements necessarily involve known and unknown
risks and uncertainties, which may cause actual performance and financial results in future periods to differ materially from any projections of
future performance or result expressed or implied by such forward-looking statements. Sharekhan/its affiliates undertakes no obligation to update
forward-looking statements if circumstances or management’s estimates or opinions should change except as required by applicable securities
laws. The reader/investors are cautioned not to place undue reliance on forward-looking statements and use their independent judgement before
taking any investment decision.
Investment in securities market are subject to market risks, read all the related documents carefully before investing. The securities quoted are for
illustration only and are not recommendatory. Registration granted by SEBI, and certification from NISM in no way guarantee performance of the
intermediary or provide any assurance of returns to investors.
Client should read the Risk Disclosure Document issued by SEBI & relevant exchanges and the T&C on www.sharekhan.com

Registration and Contact Details: Name of Research Analyst - Sharekhan Limited, Research Analyst Regn No.: INH000006183. CIN): -
U99999MH1995PLC087498. Registered Office: The Ruby, 18th Floor, 29 Senapati Bapat Marg, Dadar (West), Mumbai – 400 028, Maharashtra, INDIA.
Tel: 022-6115000.
Correspondence/Administrative Office: Gigaplex IT Park, Unit No 1001, 10th Floor, Building No.9, TTC Industrial Area, Digha, Airoli-West,
Navi Mumbai – 400 708. Tel: 022 61169000 / 61150000, Fax No. 61169699.
Other registrations of Sharekhan Ltd.: SEBI Regn. Nos.: BSE / NSE / MSEI (CASH / F&O / CD) / MCX - Commodity: INZ000171337; DP: NSDL/CDSL-IN-
DP-365-2018; PMS: INP000005786; Mutual Fund: ARN 20669.
Compliance Officer: Ms. Binkle Oza; Tel: 022-62263303; email id: complianceofficer@sharekhan.com
For any complaints/grievance, email us at igc@sharekhan.com or you may even call Customer Service desk on - 022- 41523200 / 022-69920600

You might also like